Evidence map›Paper›PMID 32900245›Full record

ArticleImmunotherapy2020

COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy.

Cesar Martins da Costa, Zenaide Silva de Souza, Alessandra Corte Real Salgues, Guilherme Harada, Pedro Paulo Marino Rodrigues Ayres, Daniela Bulhões Vieira Nunes, Artur Katz, Rodrigo Ramella Munhoz

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Cesar Martins da CostaOncology Center, Hospital Sírio-Libanês (HSL), São Paulo, SP, Brazil.ORCID 0000-0003-1753-6840
Zenaide Silva de SouzaOncology Center, Hospital Sírio-Libanês (HSL), São Paulo, SP, Brazil.ORCID 0000-0002-9743-191X
Alessandra Corte Real SalguesOncology Center, Hospital Sírio-Libanês (HSL), São Paulo, SP, Brazil.ORCID 0000-0002-9642-2237
Guilherme HaradaOncology Center, Hospital Sírio-Libanês (HSL), São Paulo, SP, Brazil.ORCID 0000-0003-4012-3251
Pedro Paulo Marino Rodrigues AyresIntensive Care Medicine, Hospital Sírio-Libanês (HSL), São Paulo, SP, Brazil.
Daniela Bulhões Vieira NunesIntensive Care Medicine, Hospital Sírio-Libanês (HSL), São Paulo, SP, Brazil.
Artur KatzOncology Center, Hospital Sírio-Libanês (HSL), São Paulo, SP, Brazil.
Rodrigo Ramella MunhozOncology Center, Hospital Sírio-Libanês (HSL), São Paulo, SP, Brazil.ORCID 0000-0001-8898-2798
Hospital Sírio-Libanês · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunotherapyAgedAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalBetacoronavirusCarcinoma, Merkel CellCoronavirus InfectionsCOVID-19HumansLungMalePandemicsPneumonia, ViralProgrammed Cell Death 1 ReceptorSARS-CoV-2Skin NeoplasmsAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalpembrolizumabProgrammed Cell Death 1 Receptoranti-PD-1 therapycoronavirusCOVID-19immune-related adverse eventsimmunotherapyMerkel cell carcinomaoncologypandemicSARS-CoV-2skin cancer

Identifiers

PMID32900245
PMCPMC7480322
OpenAlexW3083895942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.